Products for Research Use Only
RegisterLogin

CCT245737

CAT: 0013-GTR19167769-07Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19167769-07Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CCT245737 is a potent and highly selective oral Chk1 inhibitor, exhibiting an IC50 of 1.3 nM with over 1,000-fold selectivity against CHK2 and CDK1. It is a valuable chemical probe for investigating DNA damage response pathways in cancer research, applicable in both cellular and in vivo model studies.
CAS Number
1489389-18-5
Product Name Alternative
Checkpoint Kinase (Chk), CCT245737, CCT-245737, CCT 245737, Chk1, Inhibitor, inhibit, SRA 737, SRA737, SRA-737
Field of Research
Cell Biology
Purity
97.06% (May vary between batches)
Solubility
H2O:Insoluble;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.27 mM) ; DMSO:48.33 mg/mL (127.41 mM) ; Ethanol:5 mg/mL (13.18 mM)
Smiles
FC (F) (F) c1cnc (Nc2cnc (cn2) C#N) cc1NC[C@H]1CNCCO1
Molecular Formula
C16H16F3N7O
Molecular Weight
379.34
Storage Conditions
-20°C
Notes
For research use only.

Chemical Information

Sra-737

Chk1 Inhibitor SRA737 is an orally bioavailable inhibitor of checkpoint kinase 1 (chk1), with potential antineoplastic and chemosensitization activities. Upon oral administration, chk1 inhibitor SRA737 selectively binds to chk1, thereby preventing chk1 activity and abrogating the repair of damaged DNA. This may lead to an accumulation of damaged DNA, inhibition of cell cycle arrest, and induction of apoptosis. SRA737 may potentiate the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapeutic agents. Chk1, an adenosine triphosphate (ATP)-dependent serine/threonine kinase overexpressed in a variety of cancer cell types, mediates cell cycle checkpoint control and is essential for DNA repair; it plays a key role in resistance to chemotherapeutic agents by repairing DNA damage.

CAS Number1489389-18-5
PubChem CID72165232
IUPAC Name5-[[4-[[(2R)-morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridinyl]amino]pyrazine-2-carbonitrile
Molecular FormulaC16H16F3N7O
Molecular Weight379.34
XLogP1.1
Topological Polar Surface Area108
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count11
Rotatable Bond Count5
Heavy Atom Count27
Formal Charge0
Complexity526
SMILES
C1CO[C@H](CN1)CNC2=CC(=NC=C2C(F)(F)F)NC3=NC=C(N=C3)C#N
InChI
InChI=1S/C16H16F3N7O/c17-16(18,19)12-8-25-14(26-15-9-22-10(4-20)5-24-15)3-13(12)23-7-11-6-21-1-2-27-11/h3,5,8-9,11,21H,1-2,6-7H2,(H2,23,24,25,26)/t11-/m1/s1
InChIKey
YBYYWUUUGCNAHQ-LLVKDONJSA-N
Chemical Structure
2D Structure
2D structure of Sra-737
CAS: 1489389-18-5
CID: 72165232
Formula: C16H16F3N7O
MW: 379.34
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight379.34
XLogP31.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count11
Rotatable Bond Count5
Exact Mass379.13684265
Monoisotopic Mass379.13684265
Topological Polar Surface Area108 Ų
Heavy Atom Count27
Formal Charge0
Complexity526
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
GTR19203854CCT244747
GTR19185809-01CCT245232
GTR19170229-01CCT241736
GTR19160541-01CCT241736

Alternative Products

CatalogName
BUP12330-01CCT245737
A17239-50CCT245737 50mg
A17239-10CCT245737 10mg
C13295-1gCCT245737 (SRA737)
A17239-25CCT245737 25mg
T70553-01CCT245737 (S)
A17239-100CCT245737 100mg
A17239-5CCT245737 5mg
A17239-2CCT245737 2mg
HY-18958A(S) -CCT245737

Popular Products